Literature DB >> 29066277

Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors.

Takao Fujisawa1.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) is a member of the stress-activated mitogen-activated protein kinase kinase kinase (MAP3K) family. ASK1 is an attractive drug target, owing to its essential role in a wide variety of human diseases including neurodegenerative disorders, inflammatory diseases and cancer. Recent studies have suggested that pharmacological manipulations using small molecule ASK1 inhibitors may be beneficial in experimental human disease models. In this review, we highlight the current understanding of ASK1 inhibitors as a potential therapy for human diseases.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  ASK1 inhibitor; Apoptosis signal-regulating kinase 1 (ASK1)

Mesh:

Substances:

Year:  2017        PMID: 29066277     DOI: 10.1016/j.jbior.2017.10.004

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  5 in total

1.  Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Authors:  Ning Ji; Yuqi Yang; Chao-Yun Cai; Zi-Ning Lei; Jing-Quan Wang; Pranav Gupta; Suneet Shukla; Suresh V Ambudkar; Dexin Kong; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-10-10       Impact factor: 8.679

Review 2.  Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.

Authors:  So Yeong Cheon; Kyoung Joo Cho
Journal:  J Mol Med (Berl)       Date:  2019-01-07       Impact factor: 4.599

3.  Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors.

Authors:  Zhili Xin; Martin K Himmelbauer; J Howard Jones; Istvan Enyedy; Rab Gilfillan; Thomas Hesson; Kristopher King; Douglas J Marcotte; Paramasivam Murugan; Joseph C Santoro; Felix Gonzalez-Lopez de Turiso
Journal:  ACS Med Chem Lett       Date:  2020-02-12       Impact factor: 4.345

4.  ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasis.

Authors:  Makoto Fujimoto; Miki Kamiyama; Kosuke Fuse; Hiroki Ryuno; Takeru Odawara; Natsuki Furukawa; Yasuhiro Yoshimatsu; Tetsuro Watabe; Michaela Prchal-Murphy; Veronika Sexl; Hideaki Tahara; Yoshihiro Hayakawa; Takehiro Sato; Kohsuke Takeda; Isao Naguro; Hidenori Ichijo
Journal:  Cancer Sci       Date:  2021-03-06       Impact factor: 6.716

Review 5.  Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions.

Authors:  Veronika Obsilova; Karolina Honzejkova; Tomas Obsil
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.